1/1
2 files

A Randomized, Phase 2 Study of 24-hour Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma

figure
posted on 24.11.2020, 14:43 by James H. Peace, Hayley J. McKee, Casey C. Kopczynski

Article full text



The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History